Cancer Family
Thymus Neoplasm
CI-CAN-00000366Explore in graph →
Non-malignant104 active trials1 approved drugs1 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000366Explore in graph →
Genomics
5 cohorts mapped to this entity or its descendants. Each frequency is affected / profiled within one cohort; cohorts are shown separately because case selection, sequencing depth and definitions differ. By default the cohort with the most cases profiled is shown.
124 cases with simple somatic mutation data · 124 cases total · Data Release 46.0 · mapped to Thymoma ONTOLOGY_EXACT
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | GTF2I | Ssm | 73 | 124 | 58.9% | gdc |
| 2 | PRSS1 | Ssm | 48 | 124 | 38.7% | gdc |
| 3 | PRSS2 | Ssm | 45 | 124 | 36.3% | gdc |
| 4 | MTRNR2L6 | Ssm | 44 | 124 | 35.5% | gdc |
| 5 | FOXD4L5 | Ssm | 32 | 124 | 25.8% | gdc |
| 6 | ANKRD20A3P | Ssm | 30 | 124 | 24.2% | gdc |
| 7 | CBWD5 | Ssm | 30 | 124 | 24.2% | gdc |
| 9 | FOXD4L4 | Ssm |
Data updated 22 days agoSource updated Data Release 46.0
Cohorts mapped to a descendant (e.g. a subtype) are included because their cases belong to this entity by definition; the mapping and its match type are shown per cohort.
| 29 |
| 124 |
| 23.4% |
| gdc |
| 8 | ANKRD20A4P | Ssm | 29 | 124 | 23.4% | gdc |
| 10 | ZNF658 | Ssm | 28 | 124 | 22.6% | gdc |
| 11 | CBWD3 | Ssm | 27 | 124 | 21.8% | gdc |
| 12 | FOXD4L3 | Ssm | 27 | 124 | 21.8% | gdc |
| 14 | ANKRD20A1 | Ssm | 27 | 124 | 21.8% | gdc |
| 13 | SPATA31A3 | Ssm | 27 | 124 | 21.8% | gdc |
| 19 | OR2T29 | Ssm | 26 | 124 | 21% | gdc |
| 21 | AL627230.1 | Ssm | 26 | 124 | 21% | gdc |
| 15 | OR2T5 | Ssm | 26 | 124 | 21% | gdc |
| 25 | OR2T35 | Ssm | 26 | 124 | 21% | gdc |
| 20 | AL627230.3 | Ssm | 26 | 124 | 21% | gdc |
| 24 | OR11H12 | Ssm | 26 | 124 | 21% | gdc |
| 22 | OR2T34 | Ssm | 26 | 124 | 21% | gdc |
| 18 | OR2T10 | Ssm | 26 | 124 | 21% | gdc |
| 17 | OR2T11 | Ssm | 26 | 124 | 21% | gdc |
| 16 | OR2T3 | Ssm | 26 | 124 | 21% | gdc |
| 23 | OR2T2 | Ssm | 26 | 124 | 21% | gdc |
| 29 | PRG4 | Ssm | 25 | 124 | 20.2% | gdc |
| 26 | FMN2 | Ssm | 25 | 124 | 20.2% | gdc |
| 30 | OR2T27 | Ssm | 25 | 124 | 20.2% | gdc |
| 32 | TPR | Ssm | 25 | 124 | 20.2% | gdc |
| 27 | OR14I1 | Ssm | 25 | 124 | 20.2% | gdc |